Iovance Biotherapeutics Inc. buy Barclays PLC
Start price
29.02.24
/
50%
€15.05
Target price
28.02.25
€20.28
Performance (%)
-11.93%
Price
12:54
€13.25
Summary
This prediction is currently active. The price of Iovance Biotherapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.93%. This prediction currently runs until 28.02.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Iovance Biotherapeutics Inc. | 16.659% | 16.659% |
iShares Core DAX® | -0.922% | -1.078% |
iShares Nasdaq 100 | 0.371% | -0.556% |
iShares Nikkei 225® | 2.224% | -2.825% |
iShares S&P 500 | -0.026% | -0.788% |
Comments by Barclays_PLC for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target raised by analysts at Barclays PLC from $18.00 to $22.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat